Myoclonus Secondary to Amantadine: Case Report and Literature Review

Abstract

The usual adverse events of amantadine are dizziness, dry mouth, and peripheral edema. Postmarketing experience has revealed abnormal movements such as tremors, involuntary muscle contractions, and gait abnormalities. Herein, we report a case of an elderly male who presented with generalized twitching associated with amantadine. A 64-year-old male presenting with jerking movements within one day of onset was admitted. Sudden and involuntary distal lower and upper limb muscle twitching was observed. The subject presented subsequent brief movements when attempting to stand or hold arms antigravity. He was diagnosed with Parkinson’s disease three years ago. Eight days before the presentation to the emergency department, he consulted with his primary care physician, who prescribed amantadine to improve his motor symptoms. On the seventh day, he developed brisk abnormal movements. Laboratory exams, neuroimaging, and electroencephalogram were unremarkable. Amantadine was discontinued. After three days, the patient reported that his jerking movements had fully recovered. To the authors’ knowledge, 22 individuals with amantadine-associated myoclonus had already been reported in the literature. The pathophysiology of amantadine-induced myoclonus is probably related to serotoninergic pathways. Myoclonus secondary to amantadine was slightly more common in men. The population affected was elderly, with a mean and median age of 67.7 and 64 years.

Advances in Understanding and Managing Movement Disorders: A Comprehensive Review

“…Interestingly, neurotransmitter abnormalities were also observed with some antibiotics [63]. Also, the development of myoclonus was particularly associated with ciprofloxacin [64] and amantadine [65].…”

Understanding Drug-Induced Movement Disorders: Causes, Symptoms, and Treatment

“…Clozapine is effective in decreasing the symptoms of tardive dyskinesia in some individuals. Amantadine is an antiviral medication that has also been used to treat drug-induced Parkinsonism but has also been associated with myoclonus [125]. It increases dopamine release in the brain and may help improve motor symptoms.…”

A Literature Review of Movement Disorder Associated with Medications and Systemic Diseases

“…In some individuals with Parkinson's disease, long-term use of amantadine may lead to the development of dyskinesias. Amantadine can, in rare cases, contribute to ataxia and myoclonus [76]. Amantadine can cause dizziness and lightheadedness, which may affect balance and coordination.…”